Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scheid

Showing results (1011-1020 of 1,291) with videos related to

Pageof 130
Sort By:
Physiology & Behavior|April 29, 2014
FTO polymorphisms moderate the association of food reinforcement with energy intakeJennifer L Scheid, Katelyn A Carr, Henry Lin, et al.
ACS Nano|May 1, 2023
Cell-Membrane Coated Nanoparticles for Tumor Delineation and Qualitative Estimation of Cancer Biomarkers at Single Wavelength Excitation in Murine and Phantom ModelsIndrajit Srivastava, Benjamin Lew, Yuhan Wang, et al.
Cytotherapy|September 20, 2011
Cellular magnetic resonance imaging of monocyte-derived dendritic cell migration from healthy donors and cancer patients as assessed in a scid mouse modelXizhong Zhang, Sonali N de Chickera, Christy Willert, et al.
The Journal of Experimental Medicine|March 27, 2013
Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodiesAndrew T McGuire, Sam Hoot, Anita M Dreyer, et al.
Science (New York, N.Y.)|October 29, 2011
Increasing the potency and breadth of an HIV antibody by using structure-based rational designRon Diskin, Johannes F Scheid, Paola M Marcovecchio, et al.
Blood Advances|July 24, 2019
Randomized controlled study of ECP with methoxsalen as first-line treatment of patients with moderate to severe cGVHDMadan Jagasia, Christof Scheid, Gérard Socié, et al.
European Journal of Haematology|February 24, 2015
OCTET-CY: a phase II study to investigate the efficacy of post-transplant cyclophosphamide as sole graft-versus-host prophylaxis after allogeneic peripheral blood stem cell transplantationUdo Holtick, Jens-Markus Chemnitz, Alexander Shimabukuro-Vornhagen, et al.
Blood Advances|July 11, 2025
Sequential BCMA CAR-T Cell Therapy in Refractory Multiple MyelomaTim Richardson, Udo Holtick, Jan Hendrik Frenking, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
Predictive survival markers in patients with surgically resected non-small cell lung carcinomaJ Moldvay, P Scheid, P Wild, et al.
Blood Advances|March 27, 2026
Idecabtagene vicleucel manufacturing and clinical value of out of specification products in relapsed and refractory MMSurbhi Sidana, Yi Lin, Andrew J Cowan, et al.
Pageof 130

Showing results (1011-1020 of 1,291) with videos related to

Sort By:
Pageof 130
Physiology & Behavior|April 29, 2014
FTO polymorphisms moderate the association of food reinforcement with energy intakeJennifer L Scheid, Katelyn A Carr, Henry Lin, et al.
ACS Nano|May 1, 2023
Cell-Membrane Coated Nanoparticles for Tumor Delineation and Qualitative Estimation of Cancer Biomarkers at Single Wavelength Excitation in Murine and Phantom ModelsIndrajit Srivastava, Benjamin Lew, Yuhan Wang, et al.
Cytotherapy|September 20, 2011
Cellular magnetic resonance imaging of monocyte-derived dendritic cell migration from healthy donors and cancer patients as assessed in a scid mouse modelXizhong Zhang, Sonali N de Chickera, Christy Willert, et al.
The Journal of Experimental Medicine|March 27, 2013
Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodiesAndrew T McGuire, Sam Hoot, Anita M Dreyer, et al.
Science (New York, N.Y.)|October 29, 2011
Increasing the potency and breadth of an HIV antibody by using structure-based rational designRon Diskin, Johannes F Scheid, Paola M Marcovecchio, et al.
Blood Advances|July 24, 2019
Randomized controlled study of ECP with methoxsalen as first-line treatment of patients with moderate to severe cGVHDMadan Jagasia, Christof Scheid, Gérard Socié, et al.
European Journal of Haematology|February 24, 2015
OCTET-CY: a phase II study to investigate the efficacy of post-transplant cyclophosphamide as sole graft-versus-host prophylaxis after allogeneic peripheral blood stem cell transplantationUdo Holtick, Jens-Markus Chemnitz, Alexander Shimabukuro-Vornhagen, et al.
Blood Advances|July 11, 2025
Sequential BCMA CAR-T Cell Therapy in Refractory Multiple MyelomaTim Richardson, Udo Holtick, Jan Hendrik Frenking, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
Predictive survival markers in patients with surgically resected non-small cell lung carcinomaJ Moldvay, P Scheid, P Wild, et al.
Blood Advances|March 27, 2026
Idecabtagene vicleucel manufacturing and clinical value of out of specification products in relapsed and refractory MMSurbhi Sidana, Yi Lin, Andrew J Cowan, et al.
Pageof 130